Power Law company profile

Xenon Pharmaceuticals

Biotech & Life Sciences · Burnaby, Canada · Founded 1996 · IPO 2014 Unicorn

From families to genes, from genes to drugs.

Valuation

$4.87B

Market cap · May/2026

Revenue

$7.5M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

10 investors on Xenon Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage

GrowthWorks Capital

JP Morgan

RBC Venture Partners

InterWest Partners

Novo Ventures

Invesco Private Capital

Takeda

Series B+ 3 investors entered at this stage

NEA

Northview LifeSciences

The University of British Columbia

Global footprint

Where Xenon Pharmaceuticals has talent and traffic

Workforce by country

🇨🇦 Canada · Burnaby HQ

Book a demo for the full country breakdown

Web traffic by country

21K monthly visits
across markets

🇺🇸 United States70%

🇨🇦 Canada13.3%

🇬🇧 United Kingdom7.1%

🇮🇳 India4.8%

🇪🇸 Spain1%

Top 5 markets shown

Patent intelligence

$83M patent portfolio · 69 active families

Estimated portfolio value

$83M

1.7% of market cap · 6.3× smaller than top peer ChemoCentryx ($524M)

69 active patent families

Where Xenon Pharmaceuticals innovates DiseaseProdrugTautomerPharmacologyStereoisomerism

Where Xenon Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Xenon Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Xenon Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Xenon Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xenon Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles